Cargando…
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression
Exosomes are involved in a wide range of biological processes in human cells. Considerable evidence suggests that engineered exosomes (eExosomes) containing therapeutic agents can attenuate the oncogenic activity of human cancer cells. Despite its biomedical relevance, no information has been availa...
Autores principales: | Kase, Yutaro, Uzawa, Katsuhiro, Wagai, Sho, Yoshimura, Shusaku, Yamamoto, Jun-Ichiro, Toeda, Yuriko, Okubo, Megumi, Eizuka, Keitaro, Ando, Toshiaki, Nobuchi, Takafumi, Kawasaki, Kohei, Saito, Tomoaki, Iyoda, Manabu, Nakashima, Dai, Kasamatsu, Atsushi, Tanzawa, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960743/ https://www.ncbi.nlm.nih.gov/pubmed/33723306 http://dx.doi.org/10.1038/s41598-021-85242-1 |
Ejemplares similares
-
Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway
por: Kawasaki, Kohei, et al.
Publicado: (2021) -
SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
por: Eizuka, Keitaro, et al.
Publicado: (2019) -
Centromere Protein N Participates in Cellular Proliferation of Human Oral Cancer by Cell-Cycle Enhancement
por: Oka, Noritoshi, et al.
Publicado: (2019) -
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma
por: Uzawa, Katsuhiro, et al.
Publicado: (2019) -
Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis
por: Kita, Akihiro, et al.
Publicado: (2017)